A.G.P./ALLIANCE GLOBAL PARTNERS

590 Madison Avenue 28th Floor New York,

New York 10022

 

July 11, 2023

 

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re:	ZyVersa Therapeutics, Inc. (the “Company”)
	Registration Statement on Form S-1
	File No. 333- 272657 (the “Registration Statement”)

 

Ladies and Gentlemen:

 

Reference is made to our letter filed as correspondence via EDGAR on July 7, 2023, in which we, as the sole placement agent, requested the acceleration of the effective date of the above-captioned Registration Statement for July 10, 2023 at 5:00 p.m. Eastern Time, in accordance with Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

 

	Very truly yours,
	A.G.P./ALLIANCE GLOBAL PARTNERS
	By:	/s/ Thomas Higgins
	Name:	Thomas Higgins
	Title:	Managing Director